How many shares of ARCT does UBS Group AG own?

As of 2026-Q2, UBS Group AG holds 490,632 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS).

What is UBS Group AG's ARCT position worth?

As of 2026-Q2, UBS Group AG's ARCT position is worth $3.3M.

In 2026-Q2, UBS Group AG increased their ARCT position (+7.1% change in shares).

Based on available 13F filings, UBS Group AG first reported a position in ARCT in 2019-Q2. They have held the position across 29 quarters.

Position history for UBS Group AG's holdings in ARCTURUS THERAPEUTICS HLDGS

Current Value

$3.3M

Current Shares

490,632

Total Value Change

+$3.3M

Total Shares Change

+487,713

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	490,632	+7.1%	$3.3M	0.0%	$6.72	28
2026-Q1	Increased	458,277	+101.1%	$3.5M	0.0%	$7.91	43
2025-Q4	Increased	227,893	+42.0%	$1.4M	0.0%	$6.19	34
2025-Q3	Increased	160,486	+189.5%	$3M	0.0%	$18.78	43
2025-Q2	Decreased	55,444	-6.9%	$721,327	0.0%	$13.33	0
2025-Q1	Increased	59,544	+12.2%	$630,571	0.0%	$11.58	27
2024-Q4	Increased	53,071	+0.4%	$900,615	0.0%	$16.58	25
2024-Q3	Decreased	52,858	-15.0%	$1.2M	0.0%	$22.03	0
2024-Q2	Decreased	62,159	-42.4%	$1.5M	0.0%	$24.35	0
2024-Q1	Increased	107,939	+48.5%	$3.6M	0.0%	$33.77	37
2023-Q4	Increased	72,708	+132.6%	$2.3M	0.0%	$31.53	42
2023-Q3	Increased	31,262	+83.9%	$798,745	0.0%	$25.55	38
2023-Q2	Decreased	17,002	-58.7%	$487,618	0.0%	$26.58	0
2023-Q1	Decreased	41,206	-51.6%	$987,708	0.0%	$20.64	0
2022-Q4	Increased	85,122	+2346.0%	$1.4M	0.0%	$16.96	41
2022-Q3	Decreased	3,480	-90.6%	$52,000	0.0%	$13.98	0
2022-Q2	Decreased	36,846	-81.8%	$580,000	0.0%	$15.40	0
2022-Q1	Increased	202,235	+104.2%	$5.5M	0.0%	$27.54	44
2021-Q4	Increased	99,030	+10.3%	$3.7M	0.0%	$38.88	29
2021-Q3	Increased	89,745	+164.2%	$4.3M	0.0%	$46.75	43
2021-Q2	Decreased	33,971	-20.6%	$1.1M	0.0%	$34.56	0
2021-Q1	Increased	42,810	+52.2%	$1.8M	0.0%	$38.75	36
2020-Q4	Increased	28,128	+102.0%	$1.2M	0.0%	$46.71	41
2020-Q3	Decreased	13,928	-12.3%	$597,000	0.0%	$42.73	0
2020-Q2	Increased	15,888	+6280.7%	$743,000	0.0%	$46.98	40
2020-Q1	Decreased	249	-55.3%	$3,000	0.0%	$13.25	0
2019-Q4	New	557	-	$6,000	0.0%	$10.40	24
2019-Q3	Exited	0	-100.0%	$0	0.0%	$10.42	0
2019-Q2	New	2,919	-	$28,000	0.0%	$9.44	30